Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral
Authors:
- Takayuki MatsumaeTMTakayuki Matsumae
- Takahiro KodamaTakahiro Kodama
- Yuki TahataYTYuki Tahata
- Yuta MyojinYMYuta Myojin
- Akira DoiADAkira Doi
- Akira NishioANAkira Nishio
- Ryoko YamadaRYRyoko Yamada
- Yasutoshi NozakiYNYasutoshi Nozaki
- Masahide OshitaMOMasahide Oshita
- Naoki HiramatsuNHNaoki Hiramatsu
- Naoki MorishitaNMNaoki Morishita
- Kazuyoshi OhkawaKazuyoshi Ohkawa
Open Access
Abstract
We evaluated the value of secreted glycoprotein thrombospondin-2 (TSP-2) to predict hepatocellular carcinoma (HCC) occurrence in chronic hepatitis C (CHC) patients after Hepatitis C virus (HCV) elimination by direct-acting antiviral agents (DAAs). A total of 786 CHC patients without an HCC history who achieved a sustained virological response (SVR) with DAAs were randomly assigned 2:1, with 524 patients as the derivation cohort and 262 patients as the validation cohort. Serum TSP-2 levels at the end of treatment were measured by enzyme-linked immunosorbent assay (ELISA). In the derivation cohort, the cumulative HCC rate was significantly higher in the high TSP-2 group than in the low TSP-2 group. Multivariate Cox proportional hazards analysis revealed that TSP-2, α-fetoprotein (AFP), and the fibrosis-4 (FIB-4) index were independent HCC risk factors. The area under the receiver operating characteristic curve (AUROC) of the score calculated from these three factors (AFT score) for predicting HCC was 0.83, which was significantly higher than that of each factor alone (TSP-2: 0.70, AFP: 0.72, FIB-4: 0.69). The AFT score was used to stratify patients according to the risk of HCC occurrence in the validation cohort. Lastly, in patients with a FIB-4 index < 3.25, the serum TSP-2 levels could be used to identify those patients with a high risk of HCC occurrence. Serum TSP-2 levels are a predictive biomarker of HCC occurrence in CHC patients after HCV elimination by DAA treatment. The AFT score using TSP-2, AFP, and the FIB-4 index may identify those who require HCC surveillance.Keywords
Funding Information
- Japan Agency for Medical Research and Development (JP22fk0210074, JP22fk0210091, JP22fk0210110, JP22ama221410, JP22fk0210064, 20H03661)
- Japan Agency for Medical Research and Development (JP22fk0210074, JP22fk0210091, JP22fk0210110, JP22ama221410, JP22fk0210064, 20H03661)
- Japan Agency for Medical Research and Development (JP22fk0210074, JP22fk0210091, JP22fk0210110, JP22ama221410, JP22fk0210064, 20H03661)
- Japan Agency for Medical Research and Development (JP22fk0210074, JP22fk0210091, JP22fk0210110, JP22ama221410, JP22fk0210064, 20H03661)
- Japan Agency for Medical Research and Development (JP22fk0210074, JP22fk0210091, JP22fk0210110, JP22ama221410, JP22fk0210064, 20H03661)
- Grant-in-Aid for Scientific Research (JP22fk0210074, JP22fk0210091, JP22fk0210110, JP22ama221410, JP22fk0210064, 20H03661)
This publication has 29 references indexed in Scilit:
- Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver DiseasesHepatology, 2018
- A Comparative Study of Albumin-Bilirubin Score with Child-Pugh Score, Model for End-Stage Liver Disease Score and Indocyanine Green R15 in Predicting Posthepatectomy Liver Failure for Hepatocellular Carcinoma PatientsDigestive Diseases, 2018
- Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-Acting AntiviralsGastroenterology, 2018
- HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinomaJournal of Hepatology, 2018
- Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis CJournal of Hepatology, 2017
- Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral AgentsGastroenterology, 2017
- Hepatic stellate cells secreting WFA+‐M2BP: Its role in biological interactions with Kupffer cellsJournal of Gastroenterology and Hepatology, 2017
- Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in CanadaJournal of Hepatology, 2017
- The ThrombospondinsCold Spring Harbor Perspectives in Biology, 2011
- Noninvasive Tests for Fibrosis and Liver Stiffness Predict 5-Year Outcomes of Patients With Chronic Hepatitis CGastroenterology, 2011